14-day Premium Trial Subscription Sign Up For FreeGet Free

Chimerix Stock Forecast NASDAQ:CMRX

Price Target and Analyst Ratings

Most Recent Rating

On August 06, 2021 "Maxim Group" gave "$20.00" rating for CMRX. The price target was changed from $6.72 to 0.1%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-08-06 $20.00 Reiterated by Maxim Group $6.72 $6.72→0.1%
2021-06-07 Buy Target Raised by HC Wainwright $8.22 $18.00 → $19.00
2021-05-12 Buy Target Raised by HC Wainwright $8.17 $16.00 → $18.00
2021-05-06 Buy Target Raised by HC Wainwright $8.49 $16.00 → $18.00
2021-05-05 Buy Initiated by Maxim Group $8.72 $20.00
2021-04-29 Buy Initiated by Maxim Group $8.99 $20.00
2021-04-12 Buy Reiterated by Jonestrading $8.17 $14.00
2021-03-31 Buy Initiated by Jefferies Financial Group $9.64 $21.00
2021-03-31 Outperform Initiated by Wedbush $9.64 $21.00
2021-03-31 Buy Initiated by Jefferies Financial Group $9.64
2021-01-11 Buy Target Raised by HC Wainwright $8.81 $7.00 → $16.00
2021-01-08 Buy Reiterated by Jonestrading $8.42 $10.00
2020-08-11 Buy Reiterated by HC Wainwright $2.96 $7.00

CMRX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -14.91% during the next 3 months and, with a 90% probability hold a price between $4.58 and $6.37 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-30 $5.36 $6.41 $7.46
2021-10-01 $5.34 $6.39 $7.44
2021-10-04 $5.32 $6.37 $7.42
2021-10-05 $5.30 $6.35 $7.40
2021-10-06 $5.27 $6.33 $7.38
2021-10-07 $5.25 $6.30 $7.36
2021-10-08 $5.23 $6.28 $7.34
2021-10-11 $5.21 $6.26 $7.31
2021-10-12 $5.19 $6.24 $7.29
2021-10-13 $5.17 $6.22 $7.27
2021-10-14 $5.15 $6.20 $7.25
2021-10-15 $5.13 $6.18 $7.23
2021-10-18 $5.11 $6.16 $7.21
2021-10-19 $5.09 $6.14 $7.19
2021-10-20 $5.07 $6.12 $7.17
2021-10-21 $5.05 $6.10 $7.15
2021-10-22 $5.02 $6.08 $7.13
2021-10-25 $5.00 $6.06 $7.11
2021-10-26 $4.98 $6.03 $7.09
2021-10-27 $4.96 $6.01 $7.07
2021-10-28 $4.94 $5.99 $7.04
2021-10-29 $4.92 $5.97 $7.02
2021-11-01 $4.90 $5.95 $7.00
2021-11-02 $4.88 $5.93 $6.98
2021-11-03 $4.86 $5.91 $6.96
2021-11-04 $4.84 $5.89 $6.94
2021-11-05 $4.82 $5.87 $6.92
2021-11-08 $4.80 $5.85 $6.90
2021-11-09 $4.78 $5.83 $6.88
2021-11-10 $4.75 $5.81 $6.86

About Chimerix

Chimerix Chimerix, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral antivirals in the areas of unmet medical needs in the United States. The company’s lead product candidate is brincidofovir (CMX001), a nucleotide analog, which is in Phase III clinical trials for the prevention of cytomegalovirus (CMV) in allogeneic hematopoietic cell transplant (HCT) recipients and in kidney transplant recipients, as well as to treat adeno... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT